Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glassia in Type 1 Diabetes Mellitus
NCT01304537Phase 2Completed
- Sponsor
- Kamada Ltd.
- Start
- Jun 2011
- Primary completion
- Nov 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of alpha1-proteinase inhibitor in type 1 diabetes mellitus (T1D), sponsored by Kamada Ltd.. Started Jun 2011; status: completed.
02
Drugs
alpha1-proteinase inhibitor
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01304537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01304537.